Age Minimum
Item
minimal age 18 years
boolean
C0001779 (UMLS CUI [1,1])
C1524031 (UMLS CUI [1,2])
Coronary Artery Disease Symptomatic
Item
symptomatic coronary artery disease
boolean
C1956346 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
Patient Appropriate Therapeutic procedure Drug-Eluting Stent
Item
patient acceptable candidate for treatment with drug eluting stent in accordance with applicable guidelines
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C1322815 (UMLS CUI [1,4])
Coronary Stenosis Percentage Quantity | Reference Diameter Size | Coronary Stenosis Cover Stent Quantity
Item
presence of one or more coronary artery stenosis >50% with reference diameter 2.25-4.0mm which can be covered by one or multiple stents
boolean
C0242231 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1706462 (UMLS CUI [2,1])
C1301886 (UMLS CUI [2,2])
C0456389 (UMLS CUI [2,3])
C0242231 (UMLS CUI [3,1])
C1999244 (UMLS CUI [3,2])
C0038257 (UMLS CUI [3,3])
C1265611 (UMLS CUI [3,4])
Patient Indication | Stenotic lesion length | Vessel Diameter
Item
patient indication, lesion length and vessel diameter according to 'instructions for use' of study stents
boolean
C0030705 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
C1443266 (UMLS CUI [2])
C0005847 (UMLS CUI [3,1])
C1301886 (UMLS CUI [3,2])
Protocol Compliance | Informed Consent | Informed Consent Patient Representative
Item
patient is willing and able to cooperate with study procedures and required follow up visits and patient or legal representative has been informed and agrees by signing ec approved written informed consent.
boolean
C0525058 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
C0021430 (UMLS CUI [3,1])
C0030701 (UMLS CUI [3,2])
Childbearing Potential Pregnancy test negative Lacking | Breast Feeding
Item
women of childbearing potential who do not have a negative pregnancy test within 7 days before procedure and women who are lactating
boolean
C3831118 (UMLS CUI [1,1])
C0427780 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
C0006147 (UMLS CUI [2])
Intolerance to Aspirin | Intolerance to clopidogrel | Intolerance to Ticlopidine | Intolerance to Heparin | Intolerance to Cobalt | Intolerance to nickel | Intolerance to Chromium | Intolerance to Molybdenum | Other Coding | Intolerance to zotarolimus | Intolerance to everolimus | Intolerance to Contrast Media
Item
known intolerance to aspirin, clopidogrel or ticlopidin, heparin, cobalt, nickel, chromium, molybdenum, polymer coatings, zotarolimus, everolimus, or contrast material
boolean
C1744706 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C1744706 (UMLS CUI [2,1])
C0070166 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0040207 (UMLS CUI [3,2])
C1744706 (UMLS CUI [4,1])
C0019134 (UMLS CUI [4,2])
C1744706 (UMLS CUI [5,1])
C0009148 (UMLS CUI [5,2])
C1744706 (UMLS CUI [6,1])
C0028013 (UMLS CUI [6,2])
C1744706 (UMLS CUI [7,1])
C0008574 (UMLS CUI [7,2])
C1744706 (UMLS CUI [8,1])
C0026402 (UMLS CUI [8,2])
C1744706 (UMLS CUI [9,1])
C3846158 (UMLS CUI [9,2])
C1744706 (UMLS CUI [10,1])
C1700035 (UMLS CUI [10,2])
C1744706 (UMLS CUI [11,1])
C0541315 (UMLS CUI [11,2])
C1744706 (UMLS CUI [12,1])
C0009924 (UMLS CUI [12,2])
Study Subject Participation Status | Primary Endpoint failed
Item
participating in other trial before reaching primary endpoint
boolean
C2348568 (UMLS CUI [1])
C2986535 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
Operative Surgical Procedures Planned | Exception Antiplatelet therapy Maintained
Item
planned surgery within 6 months of pci unless dual antiplatelet therapy is maintained throughout the peri-surgical period.
boolean
C0543467 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C1096021 (UMLS CUI [2,2])
C1314677 (UMLS CUI [2,3])